Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001013762-25-004146
Filing Date
2025-03-28
Accepted
2025-03-28 16:30:45
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0235590-s3_optimizerx.htm S-3 295061
2 FORM OF INDENTURE ea023559001ex4-1_optimizerx.htm EX-4.1 337153
3 OPINION OF THE DONEY LAW FIRM ea023559001ex5-1_optimizerx.htm EX-5.1 17706
4 OPINION OF BLANK ROME LLP ea023559001ex5-2_optimizerx.htm EX-5.2 23662
5 CONSENT OF UHY LLP ea023559001ex23-1_optimizerx.htm EX-23.1 2845
6 FILING FEE TABLE ea023559001ex-fee_optimizerx.htm EX-FILING FEES 79397
7 GRAPHIC image_001.jpg GRAPHIC 4853
8 GRAPHIC ex5-1_001.jpg GRAPHIC 18299
9 GRAPHIC ex5-2_001.jpg GRAPHIC 5761
  Complete submission text file 0001013762-25-004146.txt   797068
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286224 | Film No.: 25786860
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)